Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
株式のランク #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
株価
$0.16240909
最終同期: 2025-03-04
時価総額
$35.68M
変化(1日)
0.27%
変化(1年)
0.00%
CN
取引 Dali Pharmaceuticalco.,Ltd (603963)

カテゴリー

Dali Pharmaceuticalco.,Ltd(603963)のP/S比率
August 2026 時点のP/S比率 TTM: 2.97
Dali Pharmaceuticalco.,Ltd の最新の財務報告および株価によると、現在のP/S比率(TTM)は 2.97 です。2022 年末時点でのP/S比率は 21.68 でした。
Dali Pharmaceuticalco.,Ltd の P/S 比率の履歴(2012 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 2.97 -90.20%
2023 30.30 39.75%
2022 21.68 91.44%
2021 11.32 41.15%
2020 8.02 23.66%
2019 6.49 60.68%
2018 4.04 -47.25%
2017 7.66 55.55%
2016 4.92 16.41%
2015 4.23 57.93%
2014 2.68 -12.09%
2013 3.04 -4.22%
2012 3.18 0.00%